<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Reproductive BioMedicine</title>
<title_fa>International Journal of Reproductive BioMedicine</title_fa>
<short_title>IJRM</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijrm.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2476-4108</journal_id_issn>
<journal_id_issn_online>2476-3772</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/ijrm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1387</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2008</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>6</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Editorial Comments</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa>Original Article</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>I read with interest the papers written by   Peyghambari         et al       (2008) and Niknafs       et al             nd             et al               et al               et al               et al               et al               et al               et al             (1994) did not observe any       advantage in the pregnancy rates when adding  estrogen+progesterone at luteal phase in patients  undergoing IVF (6).  In conclusion, the mechanism of luteal phase  support in assisted reproduction is complex and a  controversial issue, which demands further  experimented and clinical studies.    (2005)       noticed that administration of estrogen +  progesterone during luteal phase was involved with  higher pregnancy rates in IVF cases (5). In   contrast, Lewin     (1990) who observed that elevated       progesterone level caused decline in endometrial  receptivity following ovarian hyperstimulation in  an animal model (4).   In clinical setting, however, Alsian     (2006)       reported that ovarian hyperstimulation with luteal  support using progesterone injection altered the  endometrial receptivity. This could be related to  the alteration in the ratio of progesterone to  estrogen after administration of exogenous  gonadotropins (3). Similar results were reported by   Kramer     (2008) used ovarectomized mice       for their study.   In their previous work, Salehnia     (2008) used       superovulated mice using gonadotropins, while   Payghambari     (2008), on the other hand,       reported that injection of progesterone alone at  luteal phase did not supply an appropriate  endometrial morphology for implantation. It was  shown that application of estrogen + progesterone  provided an ideal endometrial state for embryo  implantation. They believed that hyperstimulation  of ovary may induce the morphological alterations  which may decrease the endometrial receptivity  during implantation. It is important to note that in   their study, Niknafs     day after estrogen injection. This may suggest       that endometrial proliferation in response to  estrogen is a common phenomenon in the uterus of  ovarectomized mice. They also found that  treatment of progesterone priming with estrogen  maintained the stromal proliferation, but was  unsuccessful in stimulation of epithelial cells  proliferation. The formation of uterine glands was  found to be more prominent in progesterone  treated mice than with estrogen+progesterone  treated group.   Niknafs     (2008)       on the complex issue of luteal phase support on  endometrial function in mice. I would like to  comment on the data generated from their studies.  Luteal supplementation with either hCG or  progestrone significantly improves fertility  outcomes compared with no treatment (Pritts and  Atwood, 2002) (1). Also, Walter et al (2005)  reported that estrogen promotes endometrial  proliferation, while progesterone is necessary for  stimulating endometrial proliferation (2).  Peyghambari and associates (2008) found that  uterine epithelial proliferation was optimized on   2</abstract>
	<keyword_fa></keyword_fa>
	<keyword></keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url>http://ijrm.ir/browse.php?a_code=A-10-100-132&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mohammad Ali</first_name>
	<middle_name></middle_name>
	<last_name>Khalili</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
